(Q43299909)

English

Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

scientific article published in June 2009

In more languages
default for all languages
No label defined

No description defined

Statements

Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study (English)
Susanne Rosthøj
Ulla Saarinen-Pihkala
Nordic Society of Paediatric Haematology and Oncology (NOPHO)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit